Helper virus-free, optically controllable, and two-plasmid-based production of adeno-associated virus vectors of serotypes 1 to 6

被引:275
作者
Grimm, D
Kay, MA
Kleinschmidt, JA
机构
[1] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA
[3] German Canc Res Ctr, Dept Appl Tumor Virol, D-69121 Heidelberg, Germany
关键词
adeno-associated virus; gene therapy; serotypes; vector production;
D O I
10.1016/S1525-0016(03)00095-9
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
We present a simple and safe strategy for producing high-titer adeno-associated virus (AAV) vectors derived from six different AAV serotypes (AAV-1 to AAV-6). The method, referred to as "HOT," is helper virus free, optically controllable, and based on transfection of only two plasmids, i.e., an AAV vector construct and one of six novel AAV helper plasmids. The latter were engineered to carry AAV serotype rep and cap genes together with adenoviral helper functions, as well as unique fluorescent protein expression cassettes, allowing confirmation of successful transfection and identification of the transfected plasmid. Cross-packaging of vector DNA derived from AAV-2, -3, or -6 was up to 10-fold more efficient using our novel plasmids, compared to a conservative adenovirus-dependent method. We also identified a variety of useful antibodies, allowing detection of Rep or VP proteins, or assembled capsids, of all six AAV serotypes. Finally, we describe unique cell tropisms and kinetics of transgene expression for AAV serotype vectors in primary or transformed cells from four different species. In sum, the HOT strategy and the antibodies presented here, together with the reported findings, should facilitate and support the further development of AAV serotype vectors as powerful new tools for human gene therapy.
引用
收藏
页码:839 / 850
页数:12
相关论文
共 37 条
[1]   Noninvasive gene transfer to the lung for systemic delivery of therapeutic proteins [J].
Auricchio, A ;
O'Connor, E ;
Weiner, D ;
Gao, GP ;
Hildinger, M ;
Wang, LL ;
Calcedo, R ;
Wilson, JM .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 110 (04) :499-504
[2]   Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: the retina as a model [J].
Auricchio, A ;
Kobinger, G ;
Anand, V ;
Hildinger, M ;
O'Connor, E ;
Maguire, AM ;
Wilson, JM ;
Bennett, J .
HUMAN MOLECULAR GENETICS, 2001, 10 (26) :3075-3081
[3]   Human adeno-associated virus type 5 is only distantly related to other known primate helper-dependent parvoviruses [J].
Bantel-Schaal, U ;
Delius, H ;
Schmidt, R ;
zur Hausen, H .
JOURNAL OF VIROLOGY, 1999, 73 (02) :939-947
[4]   THE CRYPTIC LIFE-STYLE OF ADENOASSOCIATED VIRUS [J].
BERNS, KI ;
LINDEN, RM .
BIOESSAYS, 1995, 17 (03) :237-245
[5]   Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors [J].
Chao, HJ ;
Liu, YB ;
Rabinowitz, J ;
Li, CW ;
Samulski, RJ ;
Walsh, CE .
MOLECULAR THERAPY, 2000, 2 (06) :619-623
[6]   Adeno-associated virus (AAV) type 5 Rep protein cleaves a unique terminal resolution site compared with other AAV serotypes [J].
Chiorini, JA ;
Afione, S ;
Kotin, RM .
JOURNAL OF VIROLOGY, 1999, 73 (05) :4293-4298
[7]   Recombinant adeno-associated virus type 2, 4, and 5 vectors: Transduction of variant cell types and regions in the mammalian central nervous system [J].
Davidson, BL ;
Stein, CS ;
Heth, JA ;
Martins, I ;
Kotin, RM ;
Derksen, TA ;
Zabner, J ;
Ghodsi, A ;
Chiorini, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (07) :3428-3432
[8]   Enhancement of muscle gene delivery with pseudotyped adeno-associated virus type 5 correlates with myoblast differentiation [J].
Duan, DS ;
Yan, ZY ;
Yue, YP ;
Ding, W ;
Engelhardt, JF .
JOURNAL OF VIROLOGY, 2001, 75 (16) :7662-7671
[9]   Adeno-associated virus type 2 protein interactions: Formation of pre-encapsidation complexes [J].
Dubielzig, R ;
King, JA ;
Weger, S ;
Kern, A ;
Kleinschmidt, JA .
JOURNAL OF VIROLOGY, 1999, 73 (11) :8989-8998
[10]  
Erles K, 1999, J MED VIROL, V59, P406, DOI 10.1002/(SICI)1096-9071(199911)59:3&lt